The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Five-year survival outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC: An update from the PACIFIC trial.
 
David R. Spigel
Leadership - ASCO (Inst)
Consulting or Advisory Role - Amgen (Inst); Aptitude Health (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Curio Science (Inst); Dracen (Inst); EMD Serono (Inst); Evelo Therapeutics (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Iksuda Therapeutics (Inst); Illumina (Inst); Intellisphere (Inst); Ipsen (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Mirati Therapeutics (Inst); Molecular Templates (Inst); Nektar (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); PharmaMar (Inst); Puma Biotechnology (Inst); Regeneron (Inst); Sanofi/Aventis (Inst); Seagen (Inst); Takeda (Inst); TRIPTYCH Health Partners (Inst); TRM Oncology (Inst)
Research Funding - Aeglea Biotherapeutics (Inst); Agios (Inst); Apollomics (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BIND Therapeutics (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celldex (Inst); Clovis Oncology (Inst); cyteir (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Elevation Oncology (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); ImClone Systems (Inst); Immunogen (Inst); Ipsen (Inst); Janssen Oncology (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Molecular Partners (Inst); Nektar (Inst); Neon Therapeutics (Inst); Novartis (Inst); Novocure (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genentech; Novartis
 
Corinne Faivre-Finn
Honoraria - AstraZeneca (Inst)
Consulting or Advisory Role - AstraZeneca (Inst)
Speakers' Bureau - AstraZeneca (Inst)
Research Funding - AstraZeneca (Inst); Elekta (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Elekta
 
Jhanelle Elaine Gray
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Axiom Healthcare Strategies; Axiom Healthcare Strategies; Blueprint Medicines; Bristol Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; EMD Serono; EMD Serono; EMD Serono; Inivata; Janssen Scientific Affairs; Lilly; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Novartis; Sanofi
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Ludwig Institute for Cancer Research (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EMD Serono; Inivata; Merck; Merck Sharp & Dohme; Novartis
 
David Vicente
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca
 
David Planchard
Honoraria - PeerVoice; Prime Oncology
Consulting or Advisory Role - AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MedImmune; MSD Oncology; Novartis; Pfizer; Roche; Samsung
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi/Aventis (Inst); Taiho Pharmaceutical (Inst)
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Ipsen; Lilly; Merck Serono; Mirati Therapeutics; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi; Servier; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Johan F. Vansteenkiste
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi-Sankyo (Inst); Lilly (Inst); MSD Oncology (Inst); Roche (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi-Sankyo (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Research Funding - MSD (Inst)
 
Marina Chiara Garassino
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; MSD Oncology; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Daiiki Sankyo; GlaxoSmithKline; Incyte; Inivata; Janssen; Lilly; MSD; Novartis; Pfizer; Regeneron; Roche; Sanofi; Seagen; Takeda; Tiziana Life Sciences
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Celgene; Incyte; Lilly; MSD Oncology; Otsuka; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Rina Hui
Honoraria - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; Merck Sharp & Dohme; Novartis; Oncosec; Pfizer; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; Merck Sharp & Dohme; Novartis; Oncosec; Pfizer; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); OncoSec (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Novartis
 
Xavier Quantin
Honoraria - AstraZeneca; BMS France
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD Oncology; Pfizer
 
Andreas Rimner
Honoraria - More Health; Research to Practice
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Cybrexa Therapeutics; Merck
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Pfizer (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - Philips/Elekta
 
Yi-Long Wu
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb/China; Hengrui Pharmaceutical; Lilly; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche; Takeda
Research Funding - Boehringer Ingelheim (Inst); Pfizer (Inst); Roche (Inst)
 
Mustafa Ozguroglu
Honoraria - Astellas Pharma; Janssen Oncology (Inst); Novartis
Consulting or Advisory Role - AstraZeneca; MSD Oncology
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Ki Hyeong Lee
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Pfizer
 
Terufumi Kato
Employment - Lilly (I)
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; Merck Sharp & Dohme; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - AstraZeneca; Lilly; Merck Serono; MSD; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Lilly (Inst); Merck Serono; Merck Sharp & Dohme (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst)
 
Maike de Wit
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Ipsen; Jazz Pharmaceuticals
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Ipsen; Janssen; MSD; Nutricia; Sanofi
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genzyme (Inst); Ipsen (Inst); Janssen (Inst); MorphoSys (Inst); MSD (Inst); Noona Healthcare (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Pierre Fabre (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Pfizer; Takeda
 
Euan Macpherson
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Michael Newton
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Piruntha Thiyagarajah
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Scott Joseph Antonia
Consulting or Advisory Role - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; Celsius Therapeutics; EMD Serono; G1 Therapeutics; G1 Therapeutics; GlaxoSmithKline; GlaxoSmithKline; Glympse Bio; Memgen; Merck; RAPT Therapeutics; Samyang; Samyang; Tarus Therapeutics; Venn Therapeutics
Patents, Royalties, Other Intellectual Property - Oncolytic virus
Travel, Accommodations, Expenses - Achilles Therapeutics; Amgen; Celsius Therapeutics; RAPT Therapeutics